Curachem Inc. (XKON:456190)
South Korea · Delayed Price · Currency is KRW 7,210.00
0.00 (0.00%)
At close: Jun 30, 2026
Curachem Revenue
In the year 2022, Curachem had annual revenue of 6.02B KRW, down -6.94%.
Revenue
6.02B
Revenue Growth
-6.94%
P/S Ratio
2.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.65B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 6.02B | -448.71M | -6.94% |
| Dec 31, 2021 | 6.47B | 959.32M | 17.41% |
| Dec 31, 2020 | 5.51B | -348.38M | -5.95% |
| Dec 31, 2019 | 5.86B | 915.88M | 18.53% |
| Dec 31, 2018 | 4.94B | 975.29M | 24.59% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DreamCIS | 73.28B |
| HLB bioStep | 72.15B |
| C&R Research | 63.55B |
| DT&CRO CO. | 49.00B |
| Kolmar BioTech | 40.30B |
| BioInfra | 25.62B |
| P&K Skin Research Center | 23.67B |
| Penetrium Bioscience | 9.74B |